Market Cap
$394.6M
EVH
Evolent Health, Inc.
$3.47 ▲ +2.36%
Prev close $3.39Market cap$394.6M
ConsensusBuy
12-mo target$5.75 (+65.7%)
▲ Bullish
Analyst conviction 8/10
28 New Institutional Positions20 Institutional Exits Services
Snapshot
The big-picture read on EVH right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Strong Buy (79%)
Inst. Holders
50 funds
Inst. Value
$416.1M
Inst. Activity
28 buys / 20 sells
Insider Activity
$0.00 buy / $329.5K sell
Insider Net $
-$329.5K
SEC Reports
4
Price chart 30d -18.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 17, 2026 short_volume
Short Volume: EVH — 58.5% short (0.3M / 0.5M)
Short: 302,376 | Exempt: 0 | TRF Vol: 516,855 | Short Ratio: 58.5% | Off-exchange volume (dark pool
Aug 26, 2026 Insider
Aug 6, 2026 SEC McCarthy Daniel Joseph sold 65,892 shares
PRESIDENT @ $5.00 ($329.5K)
Evolent Health reported Q2 2026 revenue of $652.5M, up 46.9% YoY, but GAAP EPS was -$0.25, a miss vs the -$0.10 Street c
8-K — Impact 6/10
Evolent Health announced it will release Q2 2026 financial results on August 6, 2026, before market open. No financial r
PRESS-RELEASE — Impact 1/10
Jul 1, 2026 Insider
Shams Aammaad was granted 28,790 shares
Chief Accounting Officer
Jul 1, 2026 Insider
McCarthy Daniel Joseph was granted 302,585 shares
PRESIDENT
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
14,814,851 shares ($80.3M)
Jun 30, 2026 Inst.
MARSHALL WACE, LLP — DOUBLED
3,413,245 shares ($18.5M)
Analyst ratings buy % -16.8%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
79% rate it Buy or better · 19 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 18, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Aug 17, 2026 | TD Cowen | MAINTAIN | Buy | 56% |
| Aug 12, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| Aug 11, 2026 | Citigroup | UPGRADE | Buy | 55% |
| Aug 10, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| Jul 28, 2026 | TD Cowen | MAINTAIN | Buy | 56% |
| Jul 23, 2026 | Citigroup | DOWNGRADE | Neutral | 55% |
| Jul 21, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| Jun 30, 2026 | Truist Securities | DOWNGRADE | Hold | 55% |
| Jun 12, 2026 | Truist Securities | MAINTAIN | Buy | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 5 | 10 | 4 | 0 | 0 | 79% | |
| Aug 1, 2026 | 4 | 10 | 5 | 0 | 0 | 74% | |
| Jul 1, 2026 | 5 | 10 | 4 | 0 | 0 | 79% | |
| Jun 1, 2026 | 6 | 11 | 3 | 0 | 0 | 85% | |
| May 1, 2026 | 6 | 11 | 3 | 0 | 0 | 85% | |
| Apr 1, 2026 | 6 | 11 | 3 | 0 | 0 | 85% | |
| Mar 1, 2026 | 6 | 11 | 3 | 0 | 0 | 85% | |
| Feb 1, 2026 | 6 | 12 | 2 | 0 | 0 | 90% |
Price targets
Where 12 covering analysts think EVH trades over the next 12 months.
$5.75 +65.7% upside Strong Buy
Current$3.47 Low$3.00 Median$6.00 High$8.00 12 analysts
$3.00$8.00
Analyst rating Buy· 1.7/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 0 bullish, 0 bearish, 2 mixed, 2 neutral · avg impact 3.8/10.
MIXED8-K6/10
Evolent Health reported Q2 2026 revenue of $652.5M, up 46.9% YoY, but GAAP EPS was -$0.25, a miss vs
Aug 6, 2026
NEUTRALPRESS-RELEASE1/10
Evolent Health announced it will release Q2 2026 financial results on August 6, 2026, before market
Jul 8, 2026
NEUTRALDEFA14A2/10
Evolent Health, Inc. (EVH) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meet
Apr 24, 2026
MIXED8-K6/10
Evolent Health reported a significant year-over-year decline in revenue and net loss for 2025, drive
Feb 24, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 17, 2026
short_volume
Short Volume: EVH — 58.5% short (0.3M / 0.5M)
Short: 302,376 | Exempt: 0 | TRF Vol: 516,855 | Short Ratio: 58.5% | Off-exchange volume (dark pool + OTC)
Sep 4, 2026
short_volume
Short Volume: EVH — 58.8% short (0.3M / 0.6M)
Short: 335,115 | Exempt: 0 | TRF Vol: 569,493 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Sep 3, 2026
short_volume
Short Volume: EVH — 59.7% short (0.4M / 0.7M)
Short: 409,875 | Exempt: 0 | TRF Vol: 686,522 | Short Ratio: 59.7% | Off-exchange volume (dark pool + OTC)
Sep 1, 2026
short_volume
Short Volume: EVH — 56.2% short (0.4M / 0.7M)
Short: 402,203 | Exempt: 10 | TRF Vol: 715,368 | Short Ratio: 56.2% | Off-exchange volume (dark pool + OTC)
Aug 31, 2026
short_volume
Short Volume: EVH — 57.6% short (0.5M / 0.8M)
Short: 455,181 | Exempt: 1,033 | TRF Vol: 789,878 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.06 | $0.01–$0.09 | 20.0% | -0.1% | 5↑ 3↓ | $0.7B | 9 |
| Next Q | $0.15 | $0.12–$0.19 | 84.0% | +1.0% | 3↑ 7↓ | $0.8B | 8 |
| Current FY | $0.20 | $0.10–$0.27 | 122.1% | +0.1% | 8↑ 1↓ | $2.6B | 9 |
| Next FY | $0.40 | $0.28–$0.52 | 102.0% | +3.3% | 5↑ 5↓ | $3.3B | 9 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.060 | — |
| 7d ago | $0.060 | -0.000 |
| 30d ago | $0.060 | -0.000 |
| 60d ago | $0.054 | +0.006 |
| 90d ago | $0.054 | +0.006 |
Institutional ownership
Which big funds own EVH (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $416.1M total value (76,772,589 shares) as of 2026-Q2. Top holders: BlackRock,, MORGAN, UBS. Net buying activity: 28 institutions added/increased vs 20 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 14,814,851 | $80.3M | 19.3% | ADD +36.1% |
| MORGAN STANLEY | 8,969,012 | $48.6M | 11.7% | — |
| UBS Group AG | 6,245,283 | $33.8M | 8.1% | ADD +33.4% |
| D. E. Shaw & Co., Inc. | 5,107,561 | $27.7M | 6.7% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,787,994 | $26.0M | 6.2% | — |
| MARSHALL WACE, LLP | 3,413,245 | $18.5M | 4.4% | DOUBLED +334.8% |
| Nuveen, LLC | 3,132,085 | $17.0M | 4.1% | DOUBLED +1081.3% |
| GEODE CAPITAL MANAGEMENT, LLC | 2,904,912 | $15.7M | 3.8% | — |
| STATE STREET CORP | 2,460,431 | $13.3M | 3.2% | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,131,573 | $11.6M | 2.8% | ADD +28.6% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | ADD | 10,888,872 | 14,814,851 | +36.1% | $80.3M |
| MARSHALL WACE, LLP | DOUBLED | 785,012 | 3,413,245 | +334.8% | $18.5M |
| Nuveen, LLC | DOUBLED | 265,142 | 3,132,085 | +1081.3% | $17.0M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | DOUBLED | 610,102 | 1,601,638 | +162.5% | $8.7M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | ADD | 930,878 | 1,347,822 | +44.8% | $7.3M |
| Hudson Bay Capital Management LP | TRIM | 1,316,420 | 913,109 | -30.6% | $4.9M |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 280,854 | 875,398 | +211.7% | $4.7M |
| Walleye Capital LLC | DOUBLED | 135,948 | 845,787 | +522.1% | $4.6M |
| DIMENSIONAL FUND ADVISORS LP | TRIM | 1,790,298 | 765,020 | -57.3% | $4.1M |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | 102,867 | 699,267 | +579.8% | $3.8M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
13 insiders, 22 transactions. Net -$329.5K — $0.00 bought, $329.5K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | McCarthy Daniel Joseph | PRESIDENT | SELL | 65,892 | $5.00 | $329.5K |
| Jul 1, 2026 | Shams Aammaad | Chief Accounting Officer | AWARD | 28,790 | — | — |
| Jul 1, 2026 | McCarthy Daniel Joseph | PRESIDENT | AWARD | 302,585 | — | — |
| Jul 1, 2026 | Blackley Seth | Chief Executive Officer | AWARD | 446,102 | — | — |
| Jul 1, 2026 | McCarthy Daniel Joseph | PRESIDENT | TAX W/H | 4,582 | $5.74 | $26.3K |
| Jul 1, 2026 | Blackley Seth | Chief Executive Officer | TAX W/H | 10,297 | $5.74 | $59.1K |
| Jul 1, 2026 | Weinberg Jonathan | General Counsel | TAX W/H | 2,650 | $5.74 | $15.2K |
| Jul 1, 2026 | Weinberg Jonathan | General Counsel | AWARD | 43,055 | — | — |
| Jun 4, 2026 | Ajayi Toyin | Director | AWARD | 41,096 | — | — |
| Jun 4, 2026 | GUERTIN SHAWN M | Director | AWARD | 41,096 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for EVH.
Shares short
14,068,069
Settlement Sep 15, 2026
Change vs prior
-9.1%
Semi-monthly cycle
Days to cover
5.8
At avg daily volume
Of shares outstanding
≈12.4%
Estimate — not % of float
All EVH filing & press-release reports (4)
- 8-K reportAug 6, 2026
- PRESS-RELEASE reportJul 8, 2026
- DEFA14A reportApr 24, 2026
- 8-K reportFeb 24, 2026